Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.624 DKK -2.4% Market Closed
Market Cap: 697.8m DKK
Have any thoughts about
Bioporto A/S?
Write Note

Wall Street
Price Targets

BIOPOR Price Targets Summary
Bioporto A/S

Wall Street analysts forecast BIOPOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOPOR is 3.06 DKK with a low forecast of 3.03 DKK and a high forecast of 3.15 DKK.

Lowest
Price Target
3.03 DKK
87% Upside
Average
Price Target
3.06 DKK
88% Upside
Highest
Price Target
3.15 DKK
94% Upside
Bioporto A/S Competitors:
Price Targets
REGN
Regeneron Pharmaceuticals Inc
48% Upside
1801
Innovent Biologics Inc
53% Upside
VTGN
VistaGen Therapeutics Inc
444% Upside
BIIB
Biogen Inc
60% Upside
SPRY
ARS Pharmaceuticals Inc
108% Upside
INSM
Insmed Inc
24% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
14% Downside
SKYE
Skye Bioscience Inc
343% Upside

Revenue
Forecast

Revenue Estimate
Bioporto A/S

For the last 8 years the compound annual growth rate for Bioporto A/S's revenue is 5%. The projected CAGR for the next 2 years is 31%.

5%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioporto A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioporto A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOPOR's stock price target?
Price Target
3.06 DKK

According to Wall Street analysts, the average 1-year price target for BIOPOR is 3.06 DKK with a low forecast of 3.03 DKK and a high forecast of 3.15 DKK.

What is Bioporto A/S's Revenue forecast?
Projected CAGR
31%

For the last 8 years the compound annual growth rate for Bioporto A/S's revenue is 5%. The projected CAGR for the next 2 years is 31%.

Back to Top